Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Official title:
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
The investigators are conducting this randomized trial to determine if IBBS (Integrated
Brain, Body, and Social)intervention is an effective treatment for ADHD (attention Deficit
Hyperactivity Disorder) in two culturally distinct settings; Hamden and New Haven,
Connecticut and Beijing, China. A subgroup of the children in the US will also participate in
an EEG study before and after IBBS and will be compared to a group of typically developing
children.
IBBS combines computer-presented brain exercises with a physical education curriculum, all of
which is designed to be fun, as well as to enhance sustained attention, inhibitory control
and other executive capacities.
IBBS is a school-based program in which groups children (composed of children with ADHD,
children at risk for ADHD, and typically developing children) alternate between a classroom
setting and the gymnasium four days a week for 15 weeks. These mixed age groups will be
composed of children with ADHD, children at-risk for ADHD, and typically developing children.
Although IBBS takes place in a group setting, the computer game component individualizes
instruction to maximize benefit for each child.
During the last year of the grant, we will be introducing a pilot study of an organizational
skills training (OST) that will provide individualized parent and child training for improved
executive functioning in children randomized to the OST plus home-based program.
Purpose Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder
characterized by a failure to develop age-appropriate executive functions. Children with ADHD
struggle to sustain and direct attention, to inhibit response to task-irrelevant stimuli and
to contain and down regulate impulsive behavior. ADHD can interfere with healthy emotional
and cognitive development. It often has a negative impact not only on a child's academic
performance but also on peer and family relationships.
Medications are now widely used to treat ADHD in the US. However, we are evaluating another
approach. Based on nearly 30-years of research by scientists at Yale and in China, our
Integrated Brain, Body, and Social (IBBS) Intervention for ADHD combines computer-presented
brain exercises with a physical education curriculum, all of which is designed to be fun, as
well as to enhance sustained attention, inhibitory control and other executive capacities.
Work by other investigators has also shown that computer exercises designed specifically to
address aspects of neurocognitive dysfunction in ADHD can lead to improvements in working
memory and sustained attention; however IBBS is the first intervention to combine advanced
computer games with sports activities.
IBBS is a school-based program in which groups of 10 children (Kindergarten, First, and
Second graders) alternate between a classroom setting (45 mins) and the gymnasium (45 mins)
four days a week for 15 weeks. These mixed age groups will be composed of children with ADHD,
children at-risk for ADHD, and typically developing children. Although IBBS takes place in a
group setting, the computer game component individualizes instruction to maximize benefit for
each child.
Since the social context has a clear impact on the expression of ADHD, we have also
incorporated the "Good Behavior Game" (GBG) into these group activities. The GBG is intended
to facilitate group participation and to enhance co-operative interactions both in the
classroom and the gymnasium. The use of the GBG is another innovative feature of IBBS. Thus
far, our preliminary results have shown that IBBS leads to a fundamental increase in
cognitive abilities and focused attention.
We are conducting this randomized trial to determine if IBBS is an effective treatment for
ADHD in two culturally distinct settings; Hamden, Connecticut and Beijing, China. A subgroup
of the children in Hamden and New Haven will also participate in an EEG study before and
after IBBS. Typically Developing Children will also be recruited from the community for the
optional EEG study in order to ensure that the comparison group is well-matched with regard
to age, gender, and intelligence quotient (IQ) to those children with ADHD who have already
participated in the EEG study.
During the last year of the grant, we will be introducing a pilot study of an organizational
skills training (OST) curriculum for parents and children. We ultimately aim to create a
treatment for wide clinical application that can address primary pathology, promote more
active and more complete neural development, and normalize developmental interactions with
the environment. The treatment will be an aggressive early intervention at the time the
relevant brain regions and systems are actively developing and clinical symptoms are first
appearing.
We hypothesize in relation to clinical outcomes in the randomized controlled trial that:
1. Children receiving IBBS as after school program will show significantly greater
improvement than children receiving treatment as usual in parent and teacher symptom
ratings and laboratory tests of cognition.
2. Children's EEG data will be sensitive to the effects of IBBS.
3. Children receiving OST plus the home-based IBBS program will show significantly greater
improvement than children receiving the home-based IBBS program alone.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
Recruiting |
NCT06170996 -
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 |